川崎病(KD)又称皮肤粘膜淋巴结综合征,是感染后变态反应性疾病,其病理改变为全身性血管炎。冠状动脉瘤(CAA)和冠状动脉狭窄是该病最严重的并发症,也是致死的重要原因。近年来多数文献报告静脉滴注人血丙种球蛋白(IVIG)联合阿斯匹林(ASA)治疗KD,可降低冠状动脉损害的发生率。现将我科自1996年6月至1997年6月收治的7例KD治疗体会报告如下。资料与方法 KD患儿7例中,男4例,女3例。年龄:7个月～7岁,其中5岁以下6例。均为汉族。临床均符合日本川崎病研究委员会1984年修订的标准。发热7例(其中6例体温>39.5℃),皮疹6例,杨莓舌、口腔 Kawasaki disease (KD), also known as mucocutaneous lymph node syndrome, is post-infection allergic disease, the pathological changes of systemic vasculitis. Coronary aneurysms (CAA) and coronary artery stenosis are the most serious complication of the disease and an important cause of death. In recent years, most of the literature reported intravenous infusion of human blood gamma globulin (IVIG) combined with aspirin (ASA) in the treatment of KD, can reduce the incidence of coronary artery lesions. Now our department from June 1996 to June 1997 admitted 7 cases of KD treatment report as follows. Materials and Methods 7 cases of KD children, 4 males and 3 females. Age: 7 months to 7 years old, of which 6 cases under 5 years old. Are Han. Clinical compliance with the Kawasaki Research Commission of Japan in 1984 revised standards. Fever in 7 cases (6 cases of body temperature> 39.5 ℃), rash in 6 cases, Yang Jian ling, oral